In vitro controlled release of antihypertensive drugs intercalated into unmodified SBA-15 and MgO modified SBA-15 matrices

International Journal of Pharmaceutics

Volumn 436, Issue 1-2, 2012, Pages 111-119

  Alexa, Iuliana Florentina ^a   Ignat, Maria ^a,c   Popovici, Roxana Florentina ^b   Timpu, Daniel ^c   Popovici, Eveline ^a  

^a ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c PETRU PONI INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Romania)

Author keywords

Aliskiren; Captopril; Controlled release; Drug delivery; Mesoporous silica

Indexed keywords

ALISKIREN; CAPTOPRIL; MAGNESIUM OXIDE; NANOCARRIER; SBA 15; SILICATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFICACY; DRUG SAFETY; IN VITRO CONTROLLED RELEASE; INFRARED SPECTROSCOPY; INTERCALATION COMPLEX; NANOMEDICINE; POWDER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

AMIDES; ANTIHYPERTENSIVE AGENTS; CAPTOPRIL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FUMARATES; MAGNESIUM OXIDE; NANOPARTICLES; SILICON DIOXIDE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; X-RAY DIFFRACTION;

EID: 84865290267     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.06.036     Document Type: Article

References (30)

1. I.F. Alexa, R.F. Popovici, M. Ignat, E. Popovici, and V.A. Voicu Non-toxic nanocomposite containing captopril intercalated into green inorganic carrier Dig. J. Nanomater. Bios. 6 2011 1091 1101
2. S.L. Brantley, and N.P. Mellott Surface area and porosity of primary silicate minerals Am. Mineral. 85 2000 1767 1783
3. S. Dash, P.N. Murthy, P. Chowdhury, and L. Nath Kinetic modeling on drug release from controlled drug delivery systems Acta Pol. Pharm.-Drug Res. 67 2010 217 223
4. Q. Fengyu, Z. Guangshan, L. Huiming, Z. Weiwei, S. Jinyu, L. Shougui, and Q. Shilun A controlled release of ibuprofen by systematically tailoring the morphology of mesoporous silica materials J. Solid State Chem. 179 2006 2027 2035
5. T. Heikkilä, J. Salonen, J. Tuura, M.S. Hamdy, G. Mul, N. Kumar, T. Salmi, D.Y. Murzin, L. Laitinen, A.M. Kaukonen, J. Hirvonen, and V.P. Lehto Mesoporous silica material TUD-1 as a drug delivery system Int. J. Pharm. 331 2007 133 138
6. A.I. Khan, L.X. Lei, A.J. Norquist, and D. O'Hare Intercalation and controlled release of pharmaceutically active compounds from a layered double hydroxide Chem. Commun. 2001 2342 2343
7. Y. Kuang, L. Zhao, S. Zhang, F. Zhang, M. Dong, and S. Xu Morphologies, preparations and applications of layered double hydroxide micro-/nanostructures Materials 3 2010 5220 5235
8. Q. Lu, F. Gao, S. Komarneni, and T.E. Mallouk Ordered SBA-15 nanorod arrays inside a porous alumina membrane J. Am. Chem. Soc. 126 2004 8650 8651
9. B. Marler, U. Oberhagemann, S. Vortmann, and H. Gies Influence of the sorbate type on the XRD peak intensities of loaded MCM-41 Micropor. Mater. 6 1996 375 383
10. J.C. McElnay, T.A. Al-Furaih, C.M. Hughes, M.G. Scott, J.S. Elborn, and D.P. Nicholls The effect of pH on the buccal and sublingual absorption of captopril Eur. J. Clin. Pharmacol. 48 1995 373 379
11. R. Mellaerts, H. Kristof, E. Ken, C. Hong, M.V. Speybroeck, J.V. Humbeeck, P. Augustijns, J. Mullens, G.V. Mooter, and J.A. Martens Aging behavior of pharmaceutical formulations of itraconazole on SBA-15 ordered mesoporous silica carrier material Micropor. Mesopor. Mater. 130 2010 154 161
12. R. Mellaerts, R. Mols, J.A.G. Jammaer, C.A. Aerts, P. Annaert, J.V. Humbeeck, G. Van den Mooter, P. Augustijns, and J.A. Martens Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica Eur. J. Pharmacokinet. Biopharm. 69 2008 223
13. T. Phuong, T. Thi, T.T. Tam, N.P. Hung, J.K. Sung, and V. Vien Adsorption of lead from water by thiol-functionalized SBA-15 silicas J. Mater. Sci. 45 2010 2952 2957
14. R.F. Popovici, E.M. Seftel, G.D. Mihai, E. Popovici, and A.V. Voicu Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug J. Pharm. Sci. 100 2011 704 714
15. R.F. Popovici, I.F. Alexa, O. Novac, N. Vrinceanu, E. Popovici, C.E. Lupusoru, and A.V. Voicu Pharmacokinetics study on mesoporous silica-captopril controlled release systems Dig. J. Nanomater. Bios. 6 2011 1619 1630
16. L.Y. Qiu, and Y.H. Bae Polymer architecture and drug delivery Pharm. Res. 23 2006 1 30
17. J. Siepmann, and N.A. Peppas Higuchi equation: derivation, applications, use and misuse Int. J. Pharm. 418 2011 6 12
18. S. Shen, P.S. Chow, F. Chen, and R.B. Tan Submicron particles of SBA-15 modified with MgO as carriers for controlled drug deliver Chem. Pharm. Bull. 55 2007 985 991
19. I.I. Slowing, L.V.E. Juan, W.W. Chia, and V.S.Y. Lin Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers Adv. Drug Deliv. Rev. 60 2008 1278 1288
20. P.T. Tanev, and L.T. Vlaev An attempt at a more precise evaluation of the approach to mesopore size distribution calculations depending on the degree of pore blocking J. Colloid Interface Sci. 160 1993 110 116
21. D. Thassu, M. Deleers, and Y. Pathak Drugs and the Pharmaceutical Sciences vol. 166 2007 Informa Healthcare USA, Inc. Madison Avenue, New York p. 6
22. R.M. Vallet, A. Ramila, R.P. Real, and P. Pariente A new property of MCM-41: drug delivery system J. Chem. Mater. 13 2001 308 311
23. R.M. Vallet, and F. Balas Silica materials for medical applications Biomed. Eng. J. 2 2008 1 9
24. V.M. Speybroeck, V. Barillaro, T. Do Thi, R. Mellaerts, J. Martens, V.J. Humbeeck, J. Vermant, P. Annaert, G.V. Mooter, and P. Augustijns Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs J. Pharm. Sci. 98 2009 2648
25. R. Wang, L. Xiangwei, H. Yuan, Y. Qing, L. Xiaotian, L. Geyu, and Z. Tong The humidity-sensitive property of MgO-SBA-15 composites in one-pot synthesis Sens. Actuators B 145 2010 386 393
26. Y.L. Wei, Y.M. Wang, J.H. Zhu, and Z.Y. Wu In situ coating of SBA-15 with MgO Adv. Mater. 15 2003 1043 1045
27. Y.L. Wei, Y. Cao, and J.H. Zhu Attempts on preparing mesoporous basic material MgO/SBA-15 Stud. Surf. Sci. Catal. 154 Part A 2004 878 885
28. M. Wei, M. Pu, J. Guo, J. Han, F. Li, J. He, D.G. Evans, and X. Duan Intercalation of l-dopa into layered double hydroxides: enhancement of both chemical and stereochemical stabilities of a drug through host-guest interactions Chem. Mater. 20 2008 5169 5180
29. Z. Wu, Y. Wei, Y. Wang, and J. Zhu Direct hydrothermal synthesis of novel functional mesoporous materials Chin. Sci. Bull. 49 2004 1332 1337
30. Y. Zhanga, Z. Jinghai, J. Tongying, and W. Siling Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties Int. J. Pharm. 410 2011 118 124